PAREXEL International Corp (NASDAQ:PRXL)

CAPS Rating: 5 out of 5

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

Recs

1
Player Avatar BobLangley (78.47) Submitted: 10/20/2008 11:22:03 PM : Outperform Start Price: $21.52 PRXL Score: +43.05

Considerable backlog exists for the services of this clinical research and marketing company whose stock has taken an unjustified hit of late.

Featured Broker Partners


Advertisement